Randomized, Open-Label Trial of Primaquine against Vivax Malaria Relapse in Indonesia

Radical cure of Plasmodium vivax infection applies blood schizontocidal therapy against the acute attack and hypnozoitocidal therapy against later relapse. Chloroquine and primaquine have been used for 60 years in this manner. Resistance to chloroquine by the parasite now requires partnering other b...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sutanto, Inge, Tjahjono, Bagus, Basri, Hasan, Taylor, W. Robert, Putri, Fauziah A., Meilia, Rizka A., Setiabudy, Rianto, Nurleila, Siti, Ekawati, Lenny L., Elyazar, Iqbal, Farrar, Jeremy, Sudoyo, Herawati, Baird, J. Kevin
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2013
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3591862/
https://ncbi.nlm.nih.gov/pubmed/23254437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01879-12
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires